Middle East: Market for Hormones, Prostaglandins, Thromboxanes And Leukotrienes 2024

Market Size for Hormones, Prostaglandins, Thromboxanes And Leukotrienes in the Middle East

In 2023, after two years of growth, there was decline in the Middle Eastern market for hormones, prostaglandins, thromboxanes and leukotrienes, when its value decreased by X% to $X. Over the period under review, consumption saw strong growth. As a result, consumption reached the peak level of $X. From 2020 to 2023, the growth of the market failed to regain momentum.

Production of Hormones, Prostaglandins, Thromboxanes And Leukotrienes in the Middle East

In value terms, hormones, prostaglandins, thromboxanes and leukotrienes production skyrocketed to $X in 2023 estimated in export price. In general, production posted a resilient increase. The pace of growth appeared the most rapid in 2016 with an increase of X%. The level of production peaked in 2023 and is expected to retain growth in the near future.

Exports of Hormones, Prostaglandins, Thromboxanes And Leukotrienes

Exports in the Middle East

In 2023, the amount of hormones, prostaglandins, thromboxanes and leukotrienes exported in the Middle East surged to X tons, picking up by X% on the previous year. Overall, exports posted a remarkable increase. As a result, the exports reached the peak and are likely to continue growth in the immediate term.

In value terms, hormones, prostaglandins, thromboxanes and leukotrienes exports rose notably to $X in 2023. In general, exports posted a resilient expansion. The pace of growth was the most pronounced in 2018 with an increase of X% against the previous year. Over the period under review, the exports reached the peak figure in 2023 and are expected to retain growth in the near future.

Exports by Country

In 2023, Israel (X tons) was the main exporter of hormones, prostaglandins, thromboxanes and leukotrienes, mixing up X% of total exports. It was distantly followed by the United Arab Emirates (X tons), creating a X% share of total exports. Jordan (X tons) and Iran (X tons) followed a long way behind the leaders.

Israel was also the fastest-growing in terms of the hormones, prostaglandins, thromboxanes and leukotrienes exports, with a CAGR of X% from 2012 to 2023. At the same time, the United Arab Emirates (X%) and Jordan (X%) displayed positive paces of growth. Iran experienced a relatively flat trend pattern. From 2012 to 2023, the share of Israel increased by X percentage points. The shares of the other countries remained relatively stable throughout the analyzed period.

In value terms, Israel ($X) remains the largest hormones, prostaglandins, thromboxanes and leukotrienes supplier in the Middle East, comprising X% of total exports. The second position in the ranking was held by the United Arab Emirates ($X), with a X% share of total exports. It was followed by Jordan, with a X% share.

In Israel, hormones, prostaglandins, thromboxanes and leukotrienes exports increased at an average annual rate of X% over the period from 2012-2023. In the other countries, the average annual rates were as follows: the United Arab Emirates (X% per year) and Jordan (X% per year).

Export Prices by Country

In 2023, the export price in the Middle East amounted to $X per ton, waning by X% against the previous year. Over the period under review, the export price, however, enjoyed a slight expansion. The growth pace was the most rapid in 2013 an increase of X% against the previous year. Over the period under review, the export prices reached the peak figure at $X,722 per ton in 2022, and then contracted remarkably in the following year.

Prices varied noticeably by country of origin: amid the top suppliers, the country with the highest price was the United Arab Emirates ($X per ton), while Iran ($X per ton) was amongst the lowest.

From 2012 to 2023, the most notable rate of growth in terms of prices was attained by the United Arab Emirates (X%), while the other leaders experienced mixed trends in the export price figures.

Imports of Hormones, Prostaglandins, Thromboxanes And Leukotrienes

Imports in the Middle East

After three years of decline, overseas purchases of hormones, prostaglandins, thromboxanes and leukotrienes increased by X% to X tons in 2023. Over the period under review, imports, however, saw a abrupt contraction. The most prominent rate of growth was recorded in 2019 when imports increased by X% against the previous year. Over the period under review, imports attained the peak figure at X tons in 2012; however, from 2013 to 2023, imports remained at a lower figure.

In value terms, hormones, prostaglandins, thromboxanes and leukotrienes imports stood at $X in 2023. Total imports indicated a moderate increase from 2012 to 2023: its value increased at an average annual rate of X% over the last eleven-year period. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2023 figures, imports decreased by X% against 2019 indices. The most prominent rate of growth was recorded in 2019 when imports increased by X% against the previous year. Over the period under review, imports attained the maximum in 2023 and are expected to retain growth in the immediate term.

Imports by Country

The purchases of the three major importers of hormones, prostaglandins, thromboxanes and leukotrienes, namely Iran, the United Arab Emirates and Turkey, represented more than two-thirds of total import. It was distantly followed by Jordan (X tons), creating a X% share of total imports. Israel (X tons), Iraq (X tons), Kuwait (X tons) and Oman (X tons) followed a long way behind the leaders.

From 2012 to 2023, the biggest increases were recorded for the United Arab Emirates (with a CAGR of X%), while purchases for the other leaders experienced more modest paces of growth.

In value terms, Iran ($X), Turkey ($X) and Israel ($X) were the countries with the highest levels of imports in 2023, with a combined X% share of total imports. Jordan, the United Arab Emirates, Oman, Iraq and Kuwait lagged somewhat behind, together accounting for a further X%.

Oman, with a CAGR of X%, recorded the highest rates of growth with regard to the value of imports, in terms of the main importing countries over the period under review, while purchases for the other leaders experienced more modest paces of growth.

Import Prices by Country

The import price in the Middle East stood at $X,116 per ton in 2023, picking up by X% against the previous year. Import price indicated a resilient expansion from 2012 to 2023: its price increased at an average annual rate of X% over the last eleven-year period. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2023 figures, hormones, prostaglandins, thromboxanes and leukotrienes import price increased by X% against 2019 indices. The most prominent rate of growth was recorded in 2013 an increase of X% against the previous year. Over the period under review, import prices attained the peak figure at $X,240 per ton in 2014; however, from 2015 to 2023, import prices stood at a somewhat lower figure.

Prices varied noticeably by country of destination: amid the top importers, the country with the highest price was Israel ($X,428 per ton), while Kuwait ($X per ton) was amongst the lowest.

From 2012 to 2023, the most notable rate of growth in terms of prices was attained by Oman (X%), while the other leaders experienced more modest paces of growth.

Source: IndexBox Platform